Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial.

ABSTRACT:

SUBMITTER: Gillison ML 

PROVIDER: S-EPMC6541928 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature